| Patrick James Boyle, MD | |
|
539 Nw Hwy 101, Suite A, Depoe Bay, OR 97341 | |
| (541) 765-3265 | |
| Not Available |
| Full Name | Patrick James Boyle |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 539 Nw Hwy 101, Depoe Bay, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184630816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD29083 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patrick James Boyle, MD 539 Nw Hwy 101, Suite A, Depoe Bay, OR 97341 Ph: (541) 765-3265 | Patrick James Boyle, MD 539 Nw Hwy 101, Suite A, Depoe Bay, OR 97341 Ph: (541) 765-3265 |
News Archive
Results from a landmark international study using state of the art technology has revealed new genetic mutations that cause epilepsy. The findings could help to advance treatments for the most severe forms of epilepsy.
As part of Secretary of Veterans Affairs Eric K. Shinseki's effort to streamline access to benefits, the Department of Veterans Affairs (VA) has removed the signature requirement for Veterans who electronically submit an online 10-10EZ "Application for Health Benefits."
The William and Ella Owens Medical Research Foundation has awarded Texas Biomed Associate Professor Marcel Daadi, Ph.D., with a grant of more than $100,000 to test a promising FDA-approved drug for reversing age-related cognitive decline and memory deficits observed in aged baboons.
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp, announced today it has received U.S. Food and Drug Administration (FDA) clearance to market Zargis Acoustic Cardioscan (Cardioscan), the first and only computer-aided medical device to support physicians in analyzing heart sounds for the identification of suspected murmurs, a potential sign of heart disease.
A research team led by Mitchell Lazar, MD, PhD, Director of the Institute for Diabetes, Obesity, and Metabolism at the University of Pennsylvania School of Medicine, has used state-of-the-art genetic technology to map thousands of positions where a molecular "master regulator" of fat-cell biology is nestled in DNA to control genes in these cells.
› Verified 7 days ago
Dianna L Eshleman, M.S. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Mall 101 Suite A, Depoe Bay, OR 97341 Phone: 541-765-3265 Fax: 541-768-3260 |